[Medical treatment of intestinal hemorrhage in portal hypertension].
Sauerbruch
T
T
Medizinische Universitätsklinik und Poliklinik, Allgemeine Innere Medizin, Rheinischen Friedrich-Wilhelms-Universität Bonn. Sauerbruch@uni-bonn.de
Schiedermaier
P
P
D000818:Animals; D004195:Disease Models, Animal; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006439:Hemodynamics; D006727:Hormone Antagonists / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications* / Q000503:physiopathology; D015282:Octreotide / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D013004:Somatostatin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D014667:Vasopressins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use
D005765:Gastrointestinal Agents; D006727:Hormone Antagonists; D014662:Vasoconstrictor Agents; D014667:Vasopressins; D013004:Somatostatin; D015282:Octreotide
Medikamentöse Behandlung der intestinalen Blutung bein portaler Hypertension.